Search results

219 items matching your search terms.
Filter the results.
Item type













New items since



Sort by relevance · date (newest first) · alphabetically
New models of kidney cancer may drive immunotherapy research
UNC Lineberger member William Y. Kim, MD, and his colleagues report in the journal Nature Communications they have created mouse models of both papillary and clear cell renal cell carcinoma that faithfully mimic the genetic changes seen in tumors of patients with these cancers.
Located in News / 2017 / June
Promising results found for treatment of melanoma in the brain
At the American Society of Clinical Oncology Annual Meeting 2017 in Chicago, researchers presented promising data for two different investigational drug regimens used to treat melanoma that has spread to the brain, a common and deadly complication of this cancer.
Located in News / 2017 / June
Is the finger-stick blood test necessary for type 2 diabetes treatment?
In the first large pragmatic trial of its kind in the United States, results from a UNC School of Medicine study show that checking finger-stick blood sugars may not help diabetes patients who do not use insulin.
Located in News / 2017 / June
UNC co-leads large clinical trial on new combo therapy for type 2 diabetes
New insulin degludec has comparable cardiovascular safety rates to insulin glargine U100 but with less risk of triggering low blood sugar.
Located in News / 2017 / June
Researchers show how a cancer gene protects genome organization
UNC study uncovers crucial function of a yeast enzyme Set2 whose well-conserved human counterpart is often mutated in cancers, especially kidney cancer.
Located in News / 2017 / June
Where Cigarette Smoking’s Damage is Done . . . Down to Your DNA
A new technique from UNC School of Medicine scientists led by Nobel Prize winner Aziz Sancar reveals the genome-wide DNA damage that a major carcinogen causes.
Located in News / 2017 / June
UNC researchers lead clinical trial evaluating potential treatment for postpartum depression
A phase 2, double-blind study of the investigational medication, brexanolone, in the treatment of women with severe PPD published in The Lancet. Clinical trials are currently underway at UNC.
Located in News / 2017 / June
Newly designed viral vectors could lead to improved gene therapies
UNC and University of Florida researchers created viruses to deliver gene therapies while evading pre-existing immune system responses. Aravind Asokan, PhD, led the research team at UNC.
Located in News / 2017 / June
Researchers strive to improve cancer care for older patients
At the 2017 American Society of Clinical Oncology Annual Meeting in Chicago, UNC Lineberger researchers led by Hyman B. Muss, MD, presented preliminary findings from several studies focused on older adults with cancer.
Located in News / 2017 / June
UNC/NC State spinout company raises $5.8M for ‘smart’ insulin devices
A Research Triangle Park startup founded by Zhen Gu, PhD, a biomedical engineer with joint faculty appointments at UNC and NC State University received a $5.8 million cash infusion to continue translation efforts of ‘smart’ insulin devices.
Located in News / 2017 / June